• Connor W Norwood and Eric R Wright.
• Indiana University, Richard M. Fairbanks School of Public Health, 714 N. Senate Ave., Indianapolis, IN 46202, USA; Center for Health Policy, Indiana University Purdue University - Indianapolis, 714 N. Senate Ave., Indianapolis, IN 46202, USA; Health Workforce Studies, Department of Family Medicine, Indiana University School of Medicine, 1110 W. Michigan St., Long Hall 200, Indianapolis, IN 46202, USA. Electronic address: cwnorwoo@iupui.edu.
• Res Social Adm Pharm. 2016 May 1; 12 (3): 509-14.

BackgroundPrescription drug monitoring programs (PDMPs) are proving to be valuable resources in fighting the prescription drug abuse epidemic through improved access to patient drug histories. Ninety-four percent of Indiana pharmacists have heard of Indiana's PDMP (INSPECT), only 71% of them reported using the program in 2012.ObjectiveTo identify barriers to PDMP use in outpatient pharmacies and determine the impact these barriers have on utilization.MethodsA cross-sectional study examined pharmacists' knowledge and use of INSPECT. Bivariate analyses on utilization and perceived barriers were conducted using cross-tabulations and chi-squared tests. Multiple logistic regression examined the relationship between pharmacists' level of concern with prescription drug abuse and reported utilization.ResultsPharmacists were significantly less likely to use INSPECT if they reported at least one barrier and 3 times more likely to use INSPECT if they reported no barrier. Pharmacists were 10 times more likely to use INSPECT and 18 times more likely to use it more consistently if they were extremely concerned about prescription drug abuse in their community as compared to those not at all concerned.ConclusionStrategies to improve utilization of PDMPs should look for innovative ways to limit barriers and build outpatient pharmacists' awareness of prescription drug abuse and misuse within their community.Copyright © 2016 Elsevier Inc. All rights reserved.

21 keywords...

hide…